Canada Spends Logo

Explore our Budget 2026 analysis

Grant: DRA: Canada Impact+ Research Training Awards - Doctoral

University of Toronto

$120,000.00

Evaluating De-escalation Strategies for Gram-Negative Sepsis

FY 2025-26

Summary
"Gram-negative bloodstream infections (GN BSIs) are a major cause of sepsis, prolonged hospitalization, and antimicrobial resistance worldwide. Yet, the decision on whether to narrow broad-spectrum empiric antibiotics once pathogen susceptibilities become available, remains guided more by expert opinion than by high-quality evidence. The BALANCE+ trial, a perpetual Bayesian adaptive platform evaluating multiple treatment strategies for GN BSI, provides a unique opportunity to generate robust causal evidence on this question. Evidence from the trial's de-escalation domain, which compares narrowing therapy to continuing broad-spectrum antibiotics, has the potential to directly influence clinical practice and antimicrobial stewardship policies. My proposed research will quantify the causal effects of antibiotic de-escalation on key outcomes including 30 day mortality, relapse, treatment failure, and length of stay. It will also assess how de-escalation influences subsequent antimicrobial resistance, an increasingly urgent challenge in both Canadian and global health systems. Using randomization within BALANCE+ as a natural instrument, the analysis will apply intention-to-treat methods, and Bayesian hierarchical models aligned with the platform's design to produce unbiased and policy-relevant estimates. The proposed work addresses a critical evidence gap for stewardship programs, which frequently endorse de-escalation despite limited randomized evidence in GN BSI. By identifying which patients benefit most (and which may require caution) this project will inform hospital guidelines, support safer antibiotic use, and contribute to AMR mitigation strategies. The findings will be directly relevant to Canadian healthcare settings while also advancing global efforts to optimize antimicrobial therapy in an era of rising resistance."
Program
DRA: Canada Impact+ Research Training Awards - Doctoral
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
568246
Name
Yisa Mohammed
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Canada Impact+ Research Training Awards - Doctoral
Projecttitle
Evaluating De-escalation Strategies for Gram-Negative Sepsis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA: Canada Impact+ Research Training Awards - Doctoral
Keyworddelim
Antimicrobial Stewardship; Blood Stream Infections; Gram-Negative; Treatment Outcomes
Abstract
"Gram-negative bloodstream infections (GN BSIs) are a major cause of sepsis, prolonged hospitalization, and antimicrobial resistance worldwide. Yet, the decision on whether to narrow broad-spectrum empiric antibiotics once pathogen susceptibilities become available, remains guided more by expert opinion than by high-quality evidence. The BALANCE+ trial, a perpetual Bayesian adaptive platform evaluating multiple treatment strategies for GN BSI, provides a unique opportunity to generate robust causal evidence on this question. Evidence from the trial's de-escalation domain, which compares narrowing therapy to continuing broad-spectrum antibiotics, has the potential to directly influence clinical practice and antimicrobial stewardship policies. My proposed research will quantify the causal effects of antibiotic de-escalation on key outcomes including 30 day mortality, relapse, treatment failure, and length of stay. It will also assess how de-escalation influences subsequent antimicrobial resistance, an increasingly urgent challenge in both Canadian and global health systems. Using randomization within BALANCE+ as a natural instrument, the analysis will apply intention-to-treat methods, and Bayesian hierarchical models aligned with the platform's design to produce unbiased and policy-relevant estimates. The proposed work addresses a critical evidence gap for stewardship programs, which frequently endorse de-escalation despite limited randomized evidence in GN BSI. By identifying which patients benefit most (and which may require caution) this project will inform hospital guidelines, support safer antibiotic use, and contribute to AMR mitigation strategies. The findings will be directly relevant to Canadian healthcare settings while also advancing global efforts to optimize antimicrobial therapy in an era of rising resistance."
Competitiondate
202603
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Yisa, Mohammed
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~